Planta Med 2022; 88(15): 1576
DOI: 10.1055/s-0042-1759361
Poster Session II

Selection of amorphous solid dispersion matrix/carriers for Luteolin

Authors

  • M Koromili

    1   Laboratory of Pharmaceutical Technology, Division of Pharmaceutical Technology, School of Pharmacy, Faculty of Health Sciences, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece, Thessalonki, Greece
  • A Kapourani

    1   Laboratory of Pharmaceutical Technology, Division of Pharmaceutical Technology, School of Pharmacy, Faculty of Health Sciences, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece, Thessalonki, Greece
  • A N Assimopoulou

    2   Laboratory of Organic Chemistry, School of Chemical Engineering, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece, Thessaloniki, Greece
    3   Natural Products Research Centre of Excellence-AUTH (NatPro-AUTH), Center for Interdisciplinary Research and Innovation (CIRI-AUTH), Thessaloniki 57001, Greece, Thessaloniki, Greece
  • P Barmpalexis

    1   Laboratory of Pharmaceutical Technology, Division of Pharmaceutical Technology, School of Pharmacy, Faculty of Health Sciences, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece, Thessalonki, Greece
    3   Natural Products Research Centre of Excellence-AUTH (NatPro-AUTH), Center for Interdisciplinary Research and Innovation (CIRI-AUTH), Thessaloniki 57001, Greece, Thessaloniki, Greece
 
 

Luteolin (LUT), a bioflavonoid found in many plants, shows significant formulation problems due to its poor aqueous solubility and water stability [1]. One way to overcome these limitations is to formulate the drug in suitable amorphous solid dispersions (ASDs) [2]. However, the selection of a proper ASD matrix/carrier is a nontrivial task. Therefore, the aim of the present study is to evaluate several polymeric matrix/carriers and select the most promising for the preparation of a stable LUT ASD system. Initially, the glass forming ability of LUT was evaluated using a DSC-based method [3]. Results showed that the API is a good glass former since no thermal events were observed during drugʼs quench-cooling and reheating. Then, six commonly used polymeric ASD matrix/carriers (namely povidone, PVP, coPovidone, coPVP, hydroxypropyl cellulose, HPC-SL, hydroxypropyl methyl cellulose acetate succinate, HPMC-AS, Eudragit® RS, Eud-RS, and Soluplus®, SOL) were tested as to whether they can inhibit successfully LUTʼs recrystallization. In this vein, binary ASDs were prepared using the film-casting method. Then, the ASD casts were placed in accelerating storage conditions (40 ± 2 oC/75 ± 5% RH) and the formation of LUT crystals was evaluated via polarized light microscopy. In the case of the pure API, and ASDs using Eud-RS, HPC-SL, HPMC-AS and SOL, high drugʼs recrystallization was recorded starting from day one. On the contrary, binary LUT ASDs using PVP and coPVP showed good amorphous stability, up to 21 days of storage, attributed to API-polymer strong intermolecular interactions (revealed via ATR-FTIR spectroscopy).



Publication History

Article published online:
12 December 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany